Location History:
- Vailhauques, FR (1989 - 2008)
- Antony, FR (2010)
Company Filing History:
6 out of 389 
5 out of 1,454 
2 out of 152 
Years Active: 1989-2010
Title: Bernard Tonnerre: A Pioneer in Indolizine and Piperazinylacylpiperidine Derivatives
Introduction
Bernard Tonnerre, an accomplished inventor based in Vailhauques, France, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 15 patents, Tonnerre's innovative work focuses on developing novel compounds that advance therapeutic applications.
Latest Patents
Among Tonnerre's latest patents are notable inventions related to indolizine derivatives. His patent titled "Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same" presents a method for preparing novel indolizine derivatives with specific substituents, enhancing their potential use in pharmaceutical compositions. Another significant patent is for "Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof," which details substituted 1-piperazinylacylpiperidine derivatives, marking a substantial advancement in therapeutic drug development.
Career Highlights
Throughout his career, Bernard Tonnerre has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His expertise in drug formulation and therapeutic applications has played a crucial role in the development of innovative treatments that address various medical needs.
Collaborations
Tonnerre has collaborated with several talented individuals in the industry, including Jean Wagnon and Dino Nisato. These partnerships have fostered an environment of creativity and innovation, allowing the team to push the boundaries of pharmaceutical research and development.
Conclusion
Bernard Tonnerre's work in the realm of pharmaceuticals, particularly in his recent developments of indolizine and piperazinylacylpiperidine derivatives, exemplifies his dedication to advancing medical science. With numerous patents to his name and a comprehensive background in the pharmaceutical industry, Tonnerre continues to be a significant figure in the field of medicinal chemistry.